CVE:WMD - WeedMD Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started C$1.83 -0.01 (-0.54 %) (As of 02/20/2019 04:00 PM ET)Previous CloseC$1.84Today's RangeC$1.81 - C$1.8652-Week RangeC$0.99 - C$2.49Volume455,791 shsAverage Volume720,581 shsMarket CapitalizationC$197.19 millionP/E Ratio41.59Dividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email WeedMD Inc. produces and sells medical marijuana, including dried marijuana, cannabis oil, cannabis resin, marijuana plants, and marijuana seeds in Canada. The company has a research and development supply and collaboration agreement with Revive Therapeutics Ltd. The company is headquartered in Aylmer, Canada. Receive WMD News and Ratings via Email Sign-up to receive the latest news and ratings for WMD and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange CVE Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolCVE:WMD Previous Symbol CUSIPN/A Webwww.weedmd.com Phone+1-416-5153923Debt Debt-to-Equity Ratio3.03 Current Ratio7.00 Quick Ratio5.68Price-To-Earnings Trailing P/E Ratio41.59 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$6.09 million Price / Sales32.37 Cash FlowC$0.35 per share Price / Cash Flow5.26 Book ValueC$0.72 per share Price / Book2.53Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees102 Outstanding Shares107,753,000Market CapC$197.19 million OptionableNot Optionable WeedMD (CVE:WMD) Frequently Asked Questions What is WeedMD's stock symbol? WeedMD trades on the Canadian Venture Exchange (CVE) under the ticker symbol "WMD." How were WeedMD's earnings last quarter? WeedMD Inc (CVE:WMD) announced its quarterly earnings results on Thursday, November, 29th. The company reported ($0.01) EPS for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.01). The firm had revenue of $2 million for the quarter, compared to analysts' expectations of $5.50 million. View WeedMD's Earnings History. When is WeedMD's next earnings date? WeedMD is scheduled to release their next quarterly earnings announcement on Thursday, March 7th 2019. View Earnings Estimates for WeedMD. What price target have analysts set for WMD? 1 brokerages have issued 1-year price objectives for WeedMD's shares. Their predictions range from C$3.50 to C$3.50. On average, they expect WeedMD's share price to reach C$3.50 in the next year. This suggests a possible upside of 91.3% from the stock's current price. View Analyst Price Targets for WeedMD. What is the consensus analysts' recommendation for WeedMD? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for WeedMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for WeedMD. Has WeedMD been receiving favorable news coverage? News coverage about WMD stock has been trending neutral this week, according to InfoTrie. The research firm ranks the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. WeedMD earned a news impact score of 0.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 5.0 out of 10, meaning that recent media coverage is somewhat likely to have an effect on the stock's share price in the near future. Who are some of WeedMD's key competitors? Some companies that are related to WeedMD include Supreme Cannabis (FIRE), HLS Therapeutics (HLS), Depomed (ASRT), ICC Labs (ICC), Zomedica Pharmaceuticals (ZOM), Delta 9 Cannabis (NINE), Biosyent (RX), Probiotec (PBP), Invion (IVX), Viridium Pacific Group (VIR), MMJ Group (MMJ), Cipher Pharmaceuticals (CPH), Indiva (NDVA), MGC Pharmaceuticals (MXC) and ESSA Pharma (EPI). Who are WeedMD's key executives? WeedMD's management team includes the folowing people: Mr. Keith Merker, CEO & Director (Age 46)Dr. Luc C. Duchesne Ph.D., Chief Scientific Officer (Age 58)Mr. Bruce Dawson-Scully, Advisor (Age 45)Ms. Nichola Thompson, Interim Chief Financial OfficerMr. Daniel Healey, VP of Operations How do I buy shares of WeedMD? Shares of WMD and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is WeedMD's stock price today? One share of WMD stock can currently be purchased for approximately C$1.83. How big of a company is WeedMD? WeedMD has a market capitalization of C$197.19 million and generates C$6.09 million in revenue each year. WeedMD employs 102 workers across the globe. What is WeedMD's official website? The official website for WeedMD is http://www.weedmd.com. How can I contact WeedMD? WeedMD's mailing address is 320 Bay St Suite 1600, TORONTO, ON M5H 4A6, Canada. The company can be reached via phone at +1-416-5153923. MarketBeat Community Rating for WeedMD (CVE WMD)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 64 (Vote Outperform)Underperform Votes: 50 (Vote Underperform)Total Votes: 114MarketBeat's community ratings are surveys of what our community members think about WeedMD and other stocks. Vote "Outperform" if you believe WMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WMD will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/20/2019 by MarketBeat.com StaffFeatured Article: What is a stock buyback?